On September 28, 2017, Quorum Health Corporation, (the “company”) announced that Adam Feinstein resigned from the company’s Board of Directors, and that Terry Allison Rappuhn had accepted appointment to fill the director vacancy created by Mr. Feinstein’s resignation. Prior to his resignation, Mr. Feinstein served as chair of the Audit and Compliance Committee and as a member of the Governance and Nominating Committee. Mr. Feinstein indicated his decision to resign from the company’s Board was based on his other obligations, most notably his role as the Managing Partner at Vesey Street Capital Partners, and he confirmed his resignation was not the result of any disagreement with the company with respect to its financial and auditing policies, operations or practices. Mr. Feinstein’s written notice of resignation was received and accepted by the Board on September 27, 2017, concurrently with its determination upon the recommendation of the Governance and Nominating Committee to appoint Ms. Rappuhn as a member of the Board, as Chair of the Audit and Compliance Committee and as a member of the Governance and Nominating Committee. Ms. Rappuhn, 61, brings significant financial expertise to the Board and also has extensive experience in the healthcare industry. Since 2015, she has served as a director of Akorn Inc., and has served as a member of its audit committee since 2015, a member of its nominating and corporate governance committee since 2016 and as chair of its audit committee since 2017. In June 2017, Ms. Rappuhn also joined the board of directors of Genesis Healthcare Inc., where she has served as a member of its audit committee and of its nominating, corporate governance, quality and compliance committee.